This webinar will offer participants an understanding of the Tobacco Control Act, modified risk tobacco products and how FDA’s Deeming Regulation for currently unregulated products should be tailored for tobacco products depending on where they fall under the continuum of risk.
Why Should You Attend:
FDA recently released proposed regulations that would bring tobacco products not currently regulated by the FDA under the control of the Tobacco Control Act (Deeming Regulations). This rule will substantially change the way e-cigarettes, cigars, and other tobacco products are currently manufactured, marketed and distributed. This webinar will focus on key points of the Tobacco Control Act, including the modified risk tobacco product requirements in Section 911, as well as the Deeming Regulation. It is critical for manufacturers and importers of cigars, pipe tobacco, electronic cigarettes, dissolvable tobacco and other novel tobacco products to gain a clear understanding of the requirements to be met.Areas Covered in the Webinar:
- Overview of Tobacco Control Act and Premarket Review Requirements
- Section 911 Modified Risk Tobacco Products
- FDA’s Deeming Regulation
- The Continuum of Risk of Tobacco Products
- Alternative Frameworks for Regulation
Who Will Benefit:
- General counsel and management of tobacco companies, e-cigarette companies, etc.
- Regulatory compliance associates and managers
- Medical professionals, public health and consumer advocates, and other individuals working in the smoking control/harm reduction area
- Regulatory affairs professionals and scientists who work in this area
- Manufacturers and importers of e-cigarettes and other novel tobacco products
- Suppliers in the tobacco industry
Course Provider
Azim Chowdhury,
